Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100128273 | 10012827 | 3 | F | 20140304 | 20150325 | 20140314 | 20150331 | EXP | AU-JNJFOC-20140305601 | PHARMACYCLICS | 57.15 | YR | A | F | Y | 0.00000 | 20150331 | N | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100128273 | 10012827 | 1 | PS | IBRUTINIB | IBRUTINIB | 1 | ORAL | N | 205552 | CAPSULE | |||||||||
| 100128273 | 10012827 | 2 | SS | IBRUTINIB | IBRUTINIB | 1 | ORAL | N | 102688 | 420 | MG | CAPSULE | QD | ||||||
| 100128273 | 10012827 | 3 | C | THYROXINE | LEVOTHYROXINE | 1 | ORAL | D | 0 | 50 | UG | TABLET | QD | ||||||
| 100128273 | 10012827 | 4 | C | DOCUSATE AND SENNA | 2 | D | 0 | TABLET | |||||||||||
| 100128273 | 10012827 | 5 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 6 | C | TEMAZEPAM. | TEMAZEPAM | 1 | ORAL | D | 0 | 10 | MG | TABLET | |||||||
| 100128273 | 10012827 | 7 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | ORAL | D | 0 | 25 | UG | TABLET | QD | ||||||
| 100128273 | 10012827 | 8 | C | TURMERIC | TURMERIC | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 9 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 10 | C | S-ADENOSYL-L-METHIONINE | ADEMETIONINE | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 11 | C | FOLATE | FOLATE SODIUM | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 12 | C | MAGNESIUM ASPARTATE | MAGNESIUM ASPARTATE | 1 | ORAL | D | 0 | 500 | MG | TABLETS | |||||||
| 100128273 | 10012827 | 13 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | OPHTHALMIC | D | 0 | DROPS | |||||||||
| 100128273 | 10012827 | 14 | C | COENZYME Q10 | UBIDECARENONE | 1 | D | 0 | |||||||||||
| 100128273 | 10012827 | 15 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | ORAL | D | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100128273 | 10012827 | 2 | Chronic lymphocytic leukaemia |
| 100128273 | 10012827 | 3 | Thyroid hormone replacement therapy |
| 100128273 | 10012827 | 4 | Constipation |
| 100128273 | 10012827 | 5 | Constipation |
| 100128273 | 10012827 | 6 | Sleep disorder |
| 100128273 | 10012827 | 10 | Arthralgia |
| 100128273 | 10012827 | 15 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100128273 | 10012827 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100128273 | 10012827 | Chest pain | |
| 100128273 | 10012827 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100128273 | 10012827 | 2 | 20131029 | 0 |